145 related articles for article (PubMed ID: 37032187)
1. Stereotactic Radiotherapy for Renal Cell Carcinoma: The Fallacy of (False) Positive Post-treatment Biopsy?
Correa RJM; Appu S; Siva S
Eur Urol; 2023 Sep; 84(3):287-288. PubMed ID: 37032187
[No Abstract] [Full Text] [Related]
2. Stereotactic ablative radiotherapy for primary kidney cancer.
Brown N; Breen DJ; Buckley BT; Clements W; Gangi A; Rogan C
Lancet Oncol; 2024 Jun; 25(6):e229. PubMed ID: 38821090
[No Abstract] [Full Text] [Related]
3. Stereotactic ablative radiotherapy for primary kidney cancer.
Bhargava P; Jena R; Giri RK
Lancet Oncol; 2024 Jun; 25(6):e228. PubMed ID: 38821089
[No Abstract] [Full Text] [Related]
4. Stereotactic ablative radiotherapy for primary kidney cancer - Authors' reply.
Siva S; Moon D; Pryor D
Lancet Oncol; 2024 Jun; 25(6):e230. PubMed ID: 38821091
[No Abstract] [Full Text] [Related]
5. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Ablative Radiotherapy as a Tool in Renal Cell Carcinoma for Building RAPPORT with Systemic Therapy.
Mercier C; Strijbos M; Ost P
Eur Urol; 2022 Apr; 81(4):373-374. PubMed ID: 35063309
[No Abstract] [Full Text] [Related]
7. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
9. Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?
Muacevic A; Siebels M; Tonn JC; Wowra B
World J Urol; 2005 Jul; 23(3):180-4. PubMed ID: 15791468
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Ablative Body Radiotherapy: An Emerging Weapon in the Treatment Armamentarium for Renal Cell Carcinoma or a Potential Avenue for Overtreatment?
Magee DE; Wong JK; Correa AF
Eur Urol; 2022 Dec; 82(6):623-624. PubMed ID: 35945083
[No Abstract] [Full Text] [Related]
11. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
[TBL] [Abstract][Full Text] [Related]
12. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
Müller AC; van Oorschot B; Micke O; Guckenberger M
Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
[TBL] [Abstract][Full Text] [Related]
13. Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S.
Paciotti M; Schmidt AL; Ravi P; McKay RR; Trinh QD; Choueiri TK
Oncologist; 2021 May; 26(5):e905-e906. PubMed ID: 33650184
[TBL] [Abstract][Full Text] [Related]
14. Renal-cell carcinoma.
Doh L; Curtis AE; Teh BS
N Engl J Med; 2006 Mar; 354(10):1095-6; author reply 1095-6. PubMed ID: 16525153
[No Abstract] [Full Text] [Related]
15. Re: Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.
Bourillon A; Bensalah K
Eur Urol; 2024 Jul; 86(1):76. PubMed ID: 38538423
[No Abstract] [Full Text] [Related]
16. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
18. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
19. Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: combination of stereotactic ablative body radiotherapy and radical nephrectomy for synchronous bilateral primary renal cell carcinoma.
Ali M; Gaudreault M; Siva S
BJU Int; 2023 May; 131(5):562-565. PubMed ID: 36716731
[No Abstract] [Full Text] [Related]
20. Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report.
Ishikawa Y; Yamamoto T; Umezawa R; Takahashi N; Takeda K; Suzuki Y; Jingu K
J Med Case Rep; 2022 Oct; 16(1):353. PubMed ID: 36184609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
